Podcasts about wamd

In this episode, Ayesha talked about how three more US states have filed a lawsuit against Eli Lilly over its proposed $13.5 million insulin pricing settlement. The states join six others who have been fighting Eli Lilly in court since 2017, claiming that the company hiked prices of its insulin product Humalog. The states say the $13.5 million settlement offer from Eli Lilly doesn't come close to the $1 billion worth of claims the company is facing. Hear more about the insulin pricing controversy in this episode.Ayesha also talked about the FDA approval of Regeneron's high dose Eylea (HD Eylea) for the treatment of patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME) and diabetic retinopathy (DR). Hear about how high dose Eylea offers less frequent dosing regiments, and how it will be facing Roche's blockbuster eye injection Vabysmo.Read the full articles here:More US States Take on Eli Lilly in Court Over Proposed $13.5 Million Insulin Pricing SettlementRegeneron's High Dose Eylea Gets FDA Nod for Wet AMD and DMEFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

Check out our free downloads at nascentmc.com: Implementing AMA Style – 8 Things to Get Right in Your Next Project Needs Assessments – 7 Essentials for Getting Funded Working With Your Medical Writer – 8 Ways to Get the Most out of Them See the full write ups for today's episodes at nascentmc.com/podcast ·      Elrexfio (elranatamab-bcmm) has received accelerated approval for the treatment of adult patients with relapsed or refractory multiple myeloma who have undergone multiple prior therapies. Elrexfio is a subcutaneously delivered bispecific antibody (BsAb) immunotherapy activating T-cells to kill myeloma cells. Approval is contingent upon verification of clinical benefit in further trials. The approval was granted to Pfizer. Elrexfio joins other bispecific antibody therapies from Janssen for the same condition. ·      The FDA has approved the Hepzato Kit for delivering melphalan to the liver as a treatment for metastatic uveal melanoma (mUM) with unresectable hepatic metastases. This is the only liver-directed therapy approved for this purpose. Approval was based on the FOCUS Study (NCT02678572). The manufacturer, Delcath Systems, intends to explore broader applications beyond uveal melanoma due to the therapy's potential for other tumor types. ·      A higher-dose version of Eylea (aflibercept) injection has been FDA-approved for treating wet age-related macular degeneration (wAMD), diabetic macular edema (DME), and diabetic retinopathy (DR). This approval is based on PULSAR and PHOTON pivotal trials demonstrating non-inferior vision gains at longer dosing intervals compared to the standard dose. Eylea is a VEGF inhibitor, approved for wet AMD in 2011. The approval was granted to Regeneron Pharmaceuticals. ·      Ingrezza (valbenazine) capsules have gained FDA approval for treating chorea associated with Huntington's Disease (HD). The approval is supported by clinical studies and was granted to Neurocrine Biosciences. Ingrezza was previously approved for tardive dyskinesia. ·      The FDA has approved Sohonos (palovarotene) to treat fibrodysplasia ossificans progressive (FOP), a rare bone disease causing heterotopic ossification. The approval is based on Phase 3 MOVE trial results, showing effective reduction in bone growth. Sohonos is selective for a subtype of retinoic-acid receptors. It received Orphan Drug and Breakthrough Therapy Designations and is manufactured by Ipsen. ·      Veopoz (pozelimab-bbfg) has gained FDA approval as the first treatment for CD55-deficient protein-losing enteropathy (CHAPLE disease). CHAPLE disease is a rare inherited immune disorder causing complement hyperactivation. Veopoz is a complement inhibitor indicated for patients aged 1 year and older. It received multiple designations and was granted approval to Regeneron Pharmaceuticals. Intro and outro music Garden Of Love by Pk jazz Collective Let us know if we can help with any medical writing!  

Dr. Regillo describes the results of the phase 3 prospective study of Ranibizumab Port Delivery System (PDS) for the treatment of neovascular AMD.  Reference Article: Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli G. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. Ophthalmology. 2023 Jul;130(7):735-747. doi: 10.1016/j.ophtha.2023.02.024. Epub 2023 Mar 2. PMID: 36870451.

This podcast is published open access in Ophthalmology and Therapy and is fully citeable. You can access the original published podcast article through the Ophthalmology and Therapy website and by using this link. All conflicts of interest can be found online. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The material in this podcast is included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.

Here are the links for everything discussed in Episode 69. Times are also below so feel free to skip around and get to the drugs that interest you.  (1:18) Approval of Exkivity for NSCLC (4:46) Tivdak approved for cervical cancer (7:41) New biosimilar for Luncetis approved called Byooviz (10:39) Pfizer/COVID vaccine EUA updates on booster shots Updated CDC recommendations for Pfizer COVID vaccine boostersConnect with The Rx Daily Dose:Twitter      Instagram      YouTube      Linkedin       WebsiteEmail: therxdailydose@gmail.comConnect with Ian Parnigoni PharmD. on social media:Twitter       Instagram       Linkedin  ★ Support this podcast on Patreon ★

Link to bioRxiv paper: http://biorxiv.org/cgi/content/short/2020.09.01.278259v1?rss=1 Authors: Oakley, J. D., Sodhi, S. K., Russakoff, D. B., Choudhry, N. Abstract: Purpose: To evaluate the performance of a deep learning-based, fully automated, multi-class, macular fluid segmentation algorithm relative to expert annotations in a heterogeneous population of confirmed wet age-related macular degeneration (wAMD) subjects. Methods: Twenty-two swept-source optical coherence tomography (SS-OCT) volumes of the macula from 22 from different individuals with wAMD were manually annotated by two expert graders. These results were compared using cross-validation (CV) to automated segmentations using a deep learning-based algorithm encoding spatial information about retinal tissue as an additional input to the network. The algorithm detects and delineates fluid regions in the OCT data, differentiating between intra- and sub-retinal fluid (IRF, SRF), as well as fluid resulting from in serous pigment epithelial detachments (PED). Standard metrics for fluid detection and quantification were used to evaluate performance. Results: The per slice receiver operating characteristic (ROC) area under the curves (AUCs) for each of these fluid types were 0.90, 0.94 and 0.94 for IRF, SRF and PED, respectively. Per volume results were 0.94 and 0.88 for IRF and PED (SRF being present in all cases). The correlation of fluid volume between the expert graders and the algorithm were 0.99 for IRF, 0.99 for SRF and 0.82 for PED. Conclusions: Automated, deep learning-based segmentation is able to accurately detect and quantify different macular fluid types in SS-OCT data on par with expert graders. Copy rights belong to original authors. Visit the link for more info

Michelle Christman is a Professional Wellness Speaker, Wellness Radio/TV Personality and a registered Chiropractic Assistant in The State of Maryland. She is also “recognized for extraordinary vision and passion for excellence” by the Chiropractic Leadership Alliance. As a dynamic public speaker, Michelle has empowered thousands to be healthy and well naturally for over 16 years. Her and her husband Dr. Evan Christman, a NeuroStructural Chiropractor, focus on children with Learning Differences and Autism. She has spoken on multiple platforms to hundreds of doctors and lay people, seminars, corporations, networking groups, support groups and much more. You can listen to Wake Up to Wellness with Michelle Christman live every Saturday morning from 8:00am to 9am ET. She interviews amazing doctors and celebrities from all over the world about how you and your family can be healthy and well naturally on WAMD 970am, WYRE 810, WKHZ 1460 and you can watch all over the world on www.KHZTV.com. .fusion-image-frame-bottomshadow.image-frame-shadow-136{display:inline-block}.element-bottomshadow.imageframe-136:before, .element-bottomshadow.imageframe-136:after{-webkit-box-shadow: 0 17px 10px rgba(0,0,0,0.4);box-shadow: 0 17px 10px rgba(0,0,0,0.4);} The Supplement of the Month for November 2019 is BYWG Nutrition’s Immune Boost This supplement is the newest in a growing line of premium nutritional supplements formulated by your BYWG Team. Are you feeling unwell? Is everyone around you sick? Do you need a boost – then this supplement is for you! Immune Boost is a unique combination of vitamins, minerals, mushrooms, antioxidants, and herbs to give your immune system the boost it needs – especially during the cooler months of the year. For the month of November save 10% when you order using the coupon code: ib10 .fusion-button.button-73 {border-radius:25px;}Order Immune Boost TodayBYWG's Product of the Month is Dr. Cowan’s Garden – Nutrient Dense All Organic Vegetable Powders. These powders are a clear and direct way to nutritional diversity. I have been using them and loving them since I interviewed Dr. Cowan for the podcast. You can listen to this in the podcast here. In fact I am interviewing Dr. Cowan again with a release date in November! If you are a first time buyer and you use the code BYWG you will receive 20% off your purchase. Some of my favorite powders are leek, horseradish, and burdock root. BYWG's Book of the Month: Own Your Self: The Surprising Path beyond Depression, Anxiety, and Fatigue to Reclaiming Your Authenticity, Vitality, and Freedom by Dr. Kelly Brogan. You can listen to Dr. Mike Interview Dr. Brogan here.

Listen Live! Every Saturday 8:30am on WAMD 970am radio. The KHZTV Network!

Listen Live! Every Saturday 8:30am on WAMD 970am radio. The KHZTV Network!

Welcome to a summary of the Global Retina Network Program (GRNP) meeting in Riga on wAMD and DME, including interviews with the faculty members Anat Loewenstein, Jean Francois Korobelnik, Neil Bressler and attendant Avinash Gurbaxani. Thank you for listening! EyePod@Bayer.com

Dr. Peter Kertes discusses the publication of the first year results of the CANTREAT study that investigates monthly vs treat-and-extend dosing of ranibizumab for wet AMD.    Full reference: Kertes, P. J., Galic, I. J., Greve, M., Williams, R. G., Rampakakis, E., Scarino, A., & Sheidow, T. (2019). Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular Age-related Macular Disease: 1-Year Results of the Randomized CANTREAT Study. Ophthalmology. doi:10.1016/j.ophtha.2019.01.013  

Co-hosts Leslie Greenly Smith, of the Harford County Public Library, and Libby Parris, manager of WAMD, interview Jordan Williams, Event Coordinator and Gift Officer, Harford Community College.

Co-hosts Bob Mumby and Jennifer Button, Executive Assistant to the CEO of The Harford County Public Library discuss the summer reading program with Leslie Greenly Smith and Mary Hastler from the Harford County Public Library. They also talked with Libby Parris about the Aberdeen Ironbirds games being heard on WAMD.

Listen live Saturday mornings from 8:30-9:00amE! Brandi MacDonald will empower you to achieve the ultimate relationship with yourself! You don't want to miss this! Tune in on WAMD 970am, WYRE 810, WKHZ 1460 and watch me anywhere in the world on www.KHZTV.com

This week's show comes from a recording made by WAMD 970 in Abingdon, Maryland for the Harford County Library Foundation. The program was recorded as part of a Constitution Day program and was hosted by Dr. William Allen. You can support the show by donating to the Thomas Jefferson Hour, Inc., a 501(c)(3) tax-exempt non-profit organization under tax ID #46-5726534. We're giving away three signed copies of Becoming Jefferson's People! Each hardback book will come bundled with a three-CD audiobook version, read by Clay S. Jenkinson. All new & current members of the 1776 Club will be entered to win. Become a member by December 13th to have your name included in the drawing. This January, join Clay S. Jenkinson for a Winter Retreat at Lochsa Lodge: "The American West; A New Lens: Exploring Native American Culture" The retreat is hosted by Odyssey Tours, a div of Bek, Inc. For more information, visit Odyssey Tours online or contact Becky Cawley: (208) 791-8721 or bek@odytours.net Read more on the blog.  

Weston A. Price Foundation's president Sally Fallon Morell shares tips to prepare for pregnancy and Baby's first real foods. Listen live every Saturday from 8:30-9:00am E on WAMD 970am, WYRE 810, WKHZ 1460 and watch me on www.KHZTV.com. Like us on facebook, Wake Up to Wellness with Michelle Christman, where I interview the most amazing doctors and wellness celebrities on how you can be healthy and well naturally.